Corrigendum to "KRAS G12C inhibitor outcomes in advanced non-small cell lung cancer by smoking history, performance status, and KEAP1 mutation status" [Cancer Treatment and Research Communications 47 (2026) 101227]

Xu Z, Aredo JV, Su CC, et al.

Full text

Loading PDF… Expand reader Download

Abstract

No abstract available.